Phase 1b/2 Study of Rogaratinib (BAY1163877) in Combination With Atezolizumab in Urothelial Carcinoma
Clinical trial NCT03473756 · COMPLETED
Trial details
- NCT number
- NCT03473756
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-15
- Primary completion
- 2021-07-16
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.